Orreco

About:

Orreco provides biomarker analysis for athletes, federations, and professional franchises.

Website: http://orreco.com/

Twitter/X: ORRECO1

Top Investors: LAUNCH, True Ventures, The Syndicate.com, Tom Killalea, Graeme McDowell

Description:

Orreco Their mission is to deliver a cutting edge biomarker program to optimise player performance, recovery and welfare. A tailored biomarker program can optimise player health and welfare and use sports science resources to target key or “at risk” players which will lead to increased player availability. Tailoring of recovery and player management strategies to individuals’ own biomarker profiles backs up decision making processes with data giving your team an informed recovery strategy.

Total Funding Amount:

$8.16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)orreco.com

Founders:

Andrew Hodgson, Brian Moore

Number of Employees:

11-50

Last Funding Date:

2021-01-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai